Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Investigating the Influence of Germline ATM Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies

Roberta Santos Azevedo, Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M Fernandes, Samantha J. Shupe, Marissa Terra, Anisha Patel, Joseph Yu, Jennifer R. Brown

Blood (2023) 142 (Supplement 1): 3266.

https://doi.org/10.1182/blood-2023-180136

Published: 2023

Journal Articles

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Arash Mahajerin, MD MS, Zheng-Yi Zhou, PhD, Karina Raimundo, Anisha Patel, Simeng Han, Yusi Ji, Jia Zhong, Keith Betts

Blood (2018) 132 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2018-99-112418

Published: 2018

Journal Articles

Understanding Disease Burden Among Persons with Hemophilia Α without Inhibitors

Wendy E Owens, MA, Anissa Cyhaniuk, Anisha Patel, Karina Raimundo, Elaine Chan, Richard H Ko

Blood (2018) 132 (Supplement 1): 4690.

https://doi.org/10.1182/blood-2018-99-112121

Published: 2018

Journal Articles

Management of Persons with Hemophilia A with Inhibitors After Emicizumab Approval

Anisha Patel, Karina Raimundo, Corey Stepule, Jennifer Whiteley, Richard H Ko

Blood (2018) 132 (Supplement 1): 5020.

https://doi.org/10.1182/blood-2018-99-116176

Published: 2018

Journal Articles

Model of the Impact of Delayed Inhibitor Development on Cumulative Breakthrough Bleeds and Costs in Persons with Hemophilia A Receiving Emicizumab Prophylaxis

Robert F. Sidonio, Jr., Anisha Patel, Shelby Corman, Stephen Chaplin, Karina Raimundo

Blood (2018) 132 (Supplement 1): 4710.

https://doi.org/10.1182/blood-2018-99-116410

Published: 2018

Journal Articles

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Mahek Garg, Karina Raimundo, Anisha Patel, Richard H Ko

Blood (2018) 132 (Supplement 1): 2234.

https://doi.org/10.1182/blood-2018-99-116989

Published: 2018

NARROW

Investigating the Influence of Germline ATM Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Understanding Disease Burden Among Persons with Hemophilia Α without Inhibitors

Management of Persons with Hemophilia A with Inhibitors After Emicizumab Approval

Model of the Impact of Delayed Inhibitor Development on Cumulative Breakthrough Bleeds and Costs in Persons with Hemophilia A Receiving Emicizumab Prophylaxis

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Email alerts

ASH Publications

American Society of Hematology

Investigating the Influence of Germline ATM Variants on Susceptibility to Chronic Lymphocytic Leukemia and Other Malignancies

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Understanding Disease Burden Among Persons with Hemophilia Α without Inhibitors

Management of Persons with Hemophilia A with Inhibitors After Emicizumab Approval

Model of the Impact of Delayed Inhibitor Development on Cumulative Breakthrough Bleeds and Costs in Persons with Hemophilia A Receiving Emicizumab Prophylaxis

Pain Management in Hemophilia Α: Analysis of a Large US Insurance Claims Database

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only